Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach acid symptoms are among the most commonly reported experiences on Wegovy, but the reason is often misunderstood. Semaglutide slows the movement of food through your digestive system, and that delay — not any direct irritation of the stomach lining — is what tends to trigger acid-related discomfort in most people. Wegovy (semaglutide) is a prescription-only medicine; a clinician assesses whether it's appropriate for you before any treatment begins. If stomach acid is already a concern for you, that conversation matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people searching this topic are worried that semaglutide is producing excess stomach acid or eroding the stomach lining. That isn't what the evidence shows. Wegovy works as a GLP-1 receptor agonist, binding to receptors that regulate appetite and digestion. One of its well-documented effects is slowing gastric emptying, food moves through the stomach more slowly than it would otherwise. Acid is still produced in normal amounts, but because contents sit in the stomach longer, the conditions for reflux are more easily met.
Think of it less as your stomach becoming more acidic and more as the usual clearance being delayed. That distinction matters practically, because the approach to managing symptoms shifts accordingly. You'll find a fuller explanation of how semaglutide works in the body on our semaglutide overview page.
The NHS medicines page for semaglutide lists heartburn, acid reflux, burping and indigestion among the known side effects of treatment, not as rare events, but as effects that a meaningful number of people experience. Knowing that this is an expected, manageable feature of the medicine is more useful than worrying it signals something going wrong.
The acid-related symptoms most people describe on Wegovy include a burning feeling in the chest or throat after eating, frequent burping, a sour or bitter taste in the mouth, and a general sense of fullness or pressure that doesn't ease quickly. These tend to cluster in two windows: the first few weeks of treatment, and the days following a dose increase. For most people they soften considerably once the body adjusts.
There is, however, a symptom pattern that should never be dismissed as ordinary indigestion. Severe stomach pain that persists and radiates toward the back (particularly if it comes with vomiting and doesn't ease with the usual remedies) needs prompt medical assessment. The MHRA issued a Drug Safety Update on GLP-1 medicines in January 2026 specifically highlighting acute pancreatitis as a known but infrequent side effect that can be serious. The symptom profile is distinct from ordinary acid discomfort, but it's worth being clear on the difference. If you're uncertain, seek medical help rather than waiting. If you're experiencing stomach pain more generally, our Wegovy stomach pain page covers the broader picture.
Gallbladder symptoms are also worth flagging separately: right-sided or upper-right stomach pain, particularly after fatty meals, can indicate gallstones, a condition associated with rapid weight loss of any kind.
Because the mechanism is slowed gastric emptying rather than excess acid production, some straightforward habits make a genuine difference. Smaller meals eaten more slowly give the stomach less to process at once. Leaving a gap of at least two to three hours between your last meal and lying down reduces the chance of reflux. Fatty, spicy or very rich foods tend to worsen symptoms for people already prone to acid issues, and carbonated drinks can amplify burping significantly.
Timing your injection can also help. Some people find that taking their weekly Wegovy dose in the evening means any peak in GI effects happens overnight, though this varies. Your pen lives in the fridge between uses, a useful prompt to keep a consistent weekly routine, on whatever day works for you.
Over-the-counter antacids are generally compatible with Wegovy, but any medication changes (including starting a proton pump inhibitor) should be discussed with your prescriber first, since GLP-1 medicines affect how other oral medicines are absorbed. Our Wegovy treatment page covers the full side-effect picture if you want the wider context. For questions about similar symptoms that come on more suddenly, the Wegovy stomach flu page is a useful read.
One further note on the stomach itself: if you're curious about the physical question of where Wegovy goes once injected, the Wegovy in stomach guide addresses the injection-site question directly. And if you've been considering injectable versus oral routes, the treatment overview sets out what's available.
If acid symptoms are making treatment feel hard to stick with, our guide to stomach ache on Wegovy is a good place to start before anything else changes. Speaking to a prescriber about what you're experiencing is more useful than stopping or adjusting the dose on your own. When you're ready, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not a chatbot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.